Delivery Order SPE2DB24D1021-SPE2DB25FFAWA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,325.77 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,671.43 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 22, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,289.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed price delivery order, awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a direct purchase under a larger contract vehicle. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,665.23 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This non-competitive delivery order represents a firm fixed price transaction with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,170.35 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (60 count), a combination inhalation powder used to treat chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,143.65 for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a direct purchase under an existing contract vehicle. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $21,179.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This firm fixed-price delivery order is scheduled for completion by August 7, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside restrictions, reflecting AmerisourceBergen's qualification to compete...
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-dose units), with a ceiling value of $3,023.81. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is set for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,604.40 for TRELEGY ELLIPTA 100-62.5-25 (60 count), a combination inhalation powder used in respiratory disease treatment. Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAWADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,279.40 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs through the Defense Logistics Agency's distribution network. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp fulfills medical procurement requirements for multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through competitively awarded contracts demonstrating its capability to meet diverse federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/18/25 |